Germolene antiseptic ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

germolene antiseptic ointment

bayer plc - zinc oxide; octafonium chloride; phenol; methyl salicylate; wool fat; starch; liquid paraffin light; white soft paraffin; yellow soft paraffin - cutaneous ointment - 65.5mg/1gram ; 3mg/1gram ; 11.9mg/1gram ; 30mg/1gram ; 350mg/1gram ; 100mg/1gram ; 79mg/1gram ; 11.3mg/1gram ; 348mg/1gram

GERMOLENE OINTMENT 6.55/3/0.3 %w/w Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

germolene ointment 6.55/3/0.3 %w/w ointment

bayer limited - zinc oxide methyl salicylate octafonium chloride phenol - ointment - 6.55/3/0.3 %w/w

GERMOLENE OINTMENT Ireland - English - HPRA (Health Products Regulatory Authority)

germolene ointment

bayer limited - zinc oxide methyl salicylate octafonium chloride phenol - ointment - 6.55/3/0.3 %w/w

Germoloids Suppositories Malta - English - Medicines Authority

germoloids suppositories

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - zinc oxide, lidocaine hydrochloride - suppository - zinc oxide 283.5 mg lidocaine hydrochloride 13.2 mg - vasoprotectives

ZINC- zinc chloride injection, solution United States - English - NLM (National Library of Medicine)

zinc- zinc chloride injection, solution

hospira, inc. - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc 1 mg/ml (zinc chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms. none known. none known.

ZINC SULFATE injection, solution United States - English - NLM (National Library of Medicine)

zinc sulfate injection, solution

american regent, inc. - zinc sulfate anhydrous (unii: 0j6z13x3wo) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc sulfate injection, usp is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain plasma levels and to prevent depletion of endogenous stores. zinc sulfate injection, usp should not be given undiluted by direct injection into a peripheral vein because of the likelihood of infusion phlebitis and the potential to increase renal loss of zinc from a bolus injection.

Zinc Sulphate Tablets Dispersible Tablet Kenya - English - Pharmacy and Poisons Board

zinc sulphate tablets dispersible tablet

alkem laboratories 167/mahatma gandhi udyog nagar dabhel daman 396 - zinc sulfate tablets usp 20mg - dispersible tablet - zinc sulfate usp (as monohydrate) 54.88mg… - mineral supplements: zinc

ZINC SULFATE INJECTION, USP SOLUTION Canada - English - Health Canada

zinc sulfate injection, usp solution

fresenius kabi canada ltd - zinc (zinc sulfate) - solution - 1mg - zinc (zinc sulfate) 1mg

ZINC SULFATE INJECTION, USP SOLUTION Canada - English - Health Canada

zinc sulfate injection, usp solution

fresenius kabi canada ltd - zinc (zinc sulfate) - solution - 5mg - zinc (zinc sulfate) 5mg

ZINC CHLORIDE 10.6mg/2mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

zinc chloride 10.6mg/2ml concentrated injection vial

phebra pty ltd - zinc chloride, quantity: 5.3 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing. indications as at 01 jan 1991 : zinc chloride injection is intended for use as an additive to compatible intravenous fluids or total parenteral nutrition solutions. it is indicated for the prevention and treatment of zinc deficiency, which may be characterised by growth deterioration, skin lesions, alopecia, impaired reproductive development and function, and delayed or inhibited wound healing.